Primary Cutaneous B-Cell Lymphoma Does NOT Typically Present with Epidermotropism or Pautrier's Microabscesses
Primary cutaneous B-cell lymphomas (PCBCL) characteristically show nodular to diffuse lymphoid infiltration with an overlying grenz zone and NO epidermal involvement—epidermotropism and Pautrier's microabscesses are classic features of T-cell lymphomas, not B-cell lymphomas 1, 2.
Key Histologic Features of PCBCL
The standard histologic pattern of PCBCL includes:
- Dermal infiltration with a grenz zone (clear zone between epidermis and tumor)
- Absence of epidermotropism as a defining characteristic
- Nodular or diffuse growth patterns confined to dermis and subcutis
This applies to all three main subtypes recognized by WHO-EORTC classification: primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL-LT) 3.
The Rare Exception: Epidermotropic B-Cell Lymphoma
While epidermotropism is NOT a typical feature, rare cases of epidermotropic B-cell lymphoma have been documented:
- These cases are exceptional and often represent secondary cutaneous involvement from systemic B-cell lymphomas (particularly splenic marginal zone lymphoma) rather than primary cutaneous disease 4
- When epidermotropism occurs in B-cell lymphoma, it creates a diagnostic pitfall by mimicking mycosis fungoides (a T-cell lymphoma) 5, 1
- Historical data from 1978 noted that epitheliotropism, while predominantly a T-cell phenomenon, can occasionally occur in B-cell lymphomas (immunocytomas), and that Pautrier microabscesses are a nonspecific aspect of epidermotropism rather than being pathognomonic for T-cell disease 6
Critical Diagnostic Pitfall
When you encounter epidermotropism in a cutaneous lymphoma, your default assumption should be T-cell lymphoma (mycosis fungoides), but you must confirm with immunophenotyping:
- Perform immunohistochemistry with B-cell markers (CD20, CD79a) and T-cell markers (CD3, CD4, CD8)
- Order clonal gene rearrangement studies (immunoglobulin for B-cells, T-cell receptor for T-cells)
- The clinical presentation alone cannot distinguish these rare epidermotropic B-cell cases from T-cell lymphomas 5, 1
Clinical Implications
For primary cutaneous B-cell lymphomas presenting with typical features (no epidermotropism):
- Indolent subtypes (PCFCL, PCMZL) require only local therapy (excision or radiotherapy), NOT systemic chemotherapy 3, 7
- Aggressive subtypes (PCDLBCL-LT) require systemic treatment with R-CHOP 7, 8
If you encounter epidermotropism in what appears to be B-cell lymphoma, strongly consider secondary cutaneous involvement from systemic disease and perform complete staging workup including bone marrow biopsy, CT imaging, and peripheral blood flow cytometry 4.